Vistagen , a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced enrollment of the first subject in a repeat dose study of ...

Dr. Rao joined Lumira Ventures in 2021 as an Associate and was promoted to Senior Associate in 2024, as she built out her skills and experience in all dimensions of the venture capital value chain.

When 13-year-old Mary Maloney suffered a rare spinal stroke following a trampoline accident in 2020, it was unclear if she'd ever be able to use her legs again. But with the aid of a new robotic ...

Srinivas Rao M.D., Ph.D. succeeds as sole Chief Executive Officer- Kevin Craig, M.D. promoted to Chief Medical Officer- Glenn ...

Novartis faces short-term challenges with patent expirations but shows long-term growth potential. Click here to read why I ...

Enveda, a biotechnology company using AI to translate life's chemistry into new medicines, today announced the appointment of ...

UK Biobank has today announced the launch of the world's most comprehensive study of the proteins circulating in our bodies, ...

Neuroscience Innovation Forum14th Annual LifeSci Advisors Corporate Access EventInvest Securities BioMed Forum 2025MidCap Events Frankfurt 2025Bio-Neuroscience 2025 MADRID and CAMBRIDGE, Mass., Jan.

There might not be a better place to find winning stocks that can slowly make you wealthy over decades than the healthcare ...

AbbVie said the impairment charge is related to last year’s $8.7 billion bet on Cerevel following the failure of the deal’s ...

Former Tesla board member Antonio Gracias offers to rescue Lykos Therapeutics with $100M deal to save its psychedelic drug ...

Seasoned advisory group including RNA, translation and commercialisation luminaries.